Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

被引:3
|
作者
Alexander, Thomas [1 ]
Lacayo, Norman J. [2 ]
Pullarkat, Vinod A. [3 ]
Jabbour, Elias J. [4 ]
Khaw, Seong Lin [5 ]
Mullighan, Charles G. [6 ,7 ]
Bajel, Ashish [8 ]
Leonard, Jessica [9 ]
Norris, Robin [10 ]
Rubnitz, Jeffrey [11 ]
Vear, Susan I. [12 ]
Schmidt, Michelle [13 ]
Tong, Bo [13 ]
Zhou, Ying [13 ]
Ross, Jeremy A. [13 ]
Rosenwinkel, Lindsey [13 ]
Jacobson, Amanda [13 ]
Kim, Su Young [13 ]
Stock, Wendy [14 ]
机构
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
[2] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[3] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Royal Childrens Hosp, Melbourne, Vic, Australia
[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA
[7] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA
[10] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[11] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[12] Nationwide Childrens Hosp, Pediat Hematol & Oncol, Columbus, OH USA
[13] AbbVie Inc, N Chicago, IL USA
[14] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood-2018-99-113464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3966
引用
收藏
页数:4
相关论文
共 50 条
  • [11] Outcome of Adults with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Samra, Bachar
    Alotaibi, Ahmad S.
    Short, Nicholas
    Khoury, Joseph
    Ravandi, Farhad
    Garris, Rebecca
    Jain, Nitin
    Konopleva, Marina
    Kantarjian, Hagop
    Jabbour, Elie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S170 - S170
  • [12] Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Place, Andrew E.
    Karol, Seth E.
    Forlenza, Christopher J.
    Cooper, Todd M.
    Fraser, Christopher
    Cario, Gunnar
    O'Brien, Maureen M.
    Gerber, Nicolas U.
    Bourquin, Jean-Pierre
    Reinhardt, Dirk
    Rubnitz, Jeffrey E.
    Opferman, Joseph T.
    Sunkersett, Gauri
    Onishi, Maika
    Dunshee, Diana R.
    Chen, Xin
    Unnebrink, Kristina
    Vishwamitra, Deeksha
    Dunbar, Fengjiao
    Badawi, Mohamed
    Ross, Jeremy A.
    Loh, Mignon L.
    PEDIATRIC BLOOD & CANCER, 2025,
  • [13] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia
    Paul, Shilpa
    Rausch, Caitlin R.
    Nasnas, Patrice E.
    Kantarjian, Hagop
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 166 - 175
  • [14] The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia
    Benjamin, Jonathan E.
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 142 - 156
  • [15] Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Adult Patients
    Oriol, Albert
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 89 - 90
  • [16] Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    El-Cheikh, Jean
    Moukalled, Nour M.
    El Darsa, Haidar
    Massoud, Radwan
    Kanj, Souha S.
    Mahfouz, Rami
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : E441 - E444
  • [17] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Deepa Bhojwani
    Richard Sposto
    Nirali N. Shah
    Vilmarie Rodriguez
    Constance Yuan
    Maryalice Stetler-Stevenson
    Maureen M. O’Brien
    Jennifer L. McNeer
    Amrana Quereshi
    Aurelie Cabannes
    Paul Schlegel
    Claudia Rossig
    Luciano Dalla-Pozza
    Keith August
    Sarah Alexander
    Jean-Pierre Bourquin
    Michel Zwaan
    Elizabeth A. Raetz
    Mignon L. Loh
    Susan R. Rheingold
    Leukemia, 2019, 33 : 884 - 892
  • [18] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali N.
    Rodriguez, Vilmarie
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    O'Brien, Maureen M.
    McNeer, Jennifer L.
    Quereshi, Amrana
    Cabannes, Aurelie
    Schlegel, Paul
    Rossig, Claudia
    Dalla-Pozza, Luciano
    August, Keith
    Alexander, Sarah
    Bourquin, Jean-Pierre
    Zwaan, Michel
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Rheingold, Susan R.
    LEUKEMIA, 2019, 33 (04) : 884 - 892
  • [19] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Aharon Ronson
    Ariella Tvito
    Jacob M. Rowe
    Current Oncology Reports, 2016, 18
  • [20] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Ronson, Aharon
    Tvito, Ariella
    Rowe, Jacob M.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (06)